HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5-carboxytetramethylrhodamine

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Xanthenes: 65
      - Rhodamines: 466
        5-carboxytetramethylrhodamine: 1

Experts

1.	Guo, Lianying: 1 article (01/2019)
2.	Liu, Chaolong: 1 article (01/2019)
3.	Liu, Jianping: 1 article (01/2019)
4.	Ma, Hua: 1 article (01/2019)
5.	Song, Bo: 1 article (01/2019)
6.	Yuan, Jingli: 1 article (01/2019)
7.	Zhang, Run: 1 article (01/2019)
8.	Zhang, Wenzhu: 1 article (01/2019)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2019 - "The nanoprobe was engineered by covalently doping two luminescent dyes, 5-carboxytetramethylrhodamine (CTMR) and BHHBCB-Eu3+, in core and shell of silica nanoparticles, followed by surface modification of the nanoparticles with FA, a cancer cell-targeting molecule. "

Related Drugs and Biologics

1.	Silicon Dioxide (Silica)
2.	Coloring Agents (Dyes)